This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • management involves avoiding a close shave, advising the patient to shave in the direction of the hair growth, growing a beard, use of chemical depilatories (1) - however often these treatment options achieve only short-lived improvement in the condition (2)

  • topical retinoic acid used alone, or in combination with a mild topical steroid, can sometimes be of benefit

  • physical modalities such as electrolysis have also been used in the treatment
    • but this technique can cause pigmentation abnormalities, scarring, and residual keratin abscesses from fragmentary destruction of the hair follicle (2)

  • only definitive cure for this condition is permanent removal of the hair follicle
    • laser hair removal with a variety of laser systems [diode (800-810 nm), pulsed Alexandrite (755 nm), Neodymium:Yttrium Aluminum Garnet (Nd:YAG (1064 nm), and pulsed non coherent light source have been used (3)

Reference:

  • Practitioner (1998), 242, 292-6.
  • Halder RM. Pseudofolliculitis barbae and related disorders. Dermatol Clin. 1988;6:407-12.
  • Perry PK, Cook-Bolden FE, Rahman Z, Jones E, Taylor SC. Defining pseudofolliculitis barbae in 2001: A review of the literature and current trends. J Am Acad Dermatol. 2002;46:S113-9
  • Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. New York: Saunders; 2012.

Create an account to add page annotations

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.